Seattle-based Adaptive Biotechnologies, which develops technology to sequence the human immune system to diagnose and treat disease, posted revenue of $30.2 million for the fourth quarter, up 25% from a… Read More
REDMOND — A groundbreaking system that would use artificial intelligence to diagnose several diseases from a single blood test may not be far off. The project, a collaboration between Microsoft… Read More
Adaptive Biotechnologies has signed a $300 million collaborative licensing agreement with Genentech to develop highly personalized cancer therapies. In addition to the up-front payment, Adaptive could receive up to $2… Read More
It’s been one day short of a year since Microsoft partnered with Adaptive Biotechnologies to create a blood test with the promise of diagnosing dozens of diseases at once. The… Read More
Adaptive Biotechnologies, the heavily-funded Seattle bioinformatics company, today announced that Diego Miralles will become the president of a new division of the company called Adaptive Therapeutics. Miralles will work to build out the… Read More